In healthy adults, a single low dose of IMP761 continues to be safe and appears to reduce the activity of T-cells, a clinical ...

After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking ...

People with multiple sclerosis have a higher risk of developing dementia than the general population, a meta-analysis reports ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

Older men with MS who used androgen-modifying therapies showed unexpectedly sustained or increased disease activity in a ...

Columnist Desiree Lama pens an open letter to her present-day self, who is in need of some support and encouragement while ...

A new low-cost generic form of Tecfidera is available in the U.S. for people with relapsing forms of MS for a fraction of the ...

New advanced imaging technology that detects specific molecules in the brain may find signs of MS lesions months earlier, a ...

Mitochondrial abnormalities, or problems in cells' powerhouses, contribute to nerve cell death linked to motor control in MS, ...

Heat sensitivity makes July 4 columnist Leigh Anne Nelson's least favorite holiday. This year, she'll be listening to her ...

The first person with multiple sclerosis was imaged in a clinical trial of a PET tracer to track myelin changes.

In people with benign MS, there is a loss of overall brain tissue but other parts of the brain may grow to help compensate ...